Spring direct naar de hoofdnavigatie of de inhoud
‘IP belongs to a company’s most powerful assets, profitable in all economic conditions.’
Raimondo Cau

Raimondo Cau

  • Hightech & Electronics
  • European and Dutch Patent Attorney
  • Associate

Before starting his career as a patent attorney, Raimondo Cau was inventor and co-founder of a medical robotics startup in which he was active as CTO until it had reached a mature stage.

Continue reading

He led the company’s R&D and IP program and was involved in several fundraising activities. He is used to keeping an overview in complex matters and dealing with various stakeholders across disciplines and levels. Raimondo has a background in Mechanical Engineering (PhD), a system-thinking attitude and is specialized in robotics, (opto)mechatronics, precision engineering and medical devices.

Working experience

  •  Patent attorney, V.O. (June 2023)
  •  CTO and cofounder, Microsure (2016 – 2020)
  • IEC/ISO technical standard committee member (2017 – 2019)
  • Project leader, Medical Robotic Technologies (2014 – 2016)
  • Mechanical designer, MAN Turbo (2008 – 2009)

Education

  • ISO 14791 Risk Management for Medical Devices (2016)
  • PhD in Mechanical Engineering, Control Systems Technology, Medical Robotics, Eindhoven University of Technology (2014)
  • MSc in Mechanical Engineering, Control Systems Technology, Precision Engineering, Eindhoven University of Technology (2009)
  • International Baccalaureate English Level A2 (near native), Cambridge Undergraduate Study (2002)

Publications

  • Cau R. Robotic Manipulator Interface for Hinged Surgical Tools. EP3363401 (A1)
  • Cau R. Surgical Robotic System with Carriage and Manipulator Unit. EP3366255 (A1)
  • Cau R. Microsurgical Robot System. EP2731535 (B1), US9351796 (B2)
  • Van Mulken TJM, Schols RM, Scharmga AMJ, Winkens B, Cau R, Schoenmakers FBF, Qiu SS, van der Hulst RRWJ. First-in-human robotic supermicrosurgery using a dedicated microsurgical robot for treating breast cancer-related lymphedema: a randomized pilot trial. Nat Commun. 2020;11(1):757
  • Van Mulken TJM, Scharmga AMJ, Schols RM, Cau R, Jonis Y, Qiu SS, van der Hulst RRWJ. The journey of creating the first dedicated platform for robot-assisted (super)microsurgery in reconstructive surgery. Eur J Plast Surg. 2020;43:1-6
  • Van Mulken TJM, Boymans CAEM, Schols RM, Cau R, Schoenmakers FBF, Hoekstra LT, Qiu SS, Selber JC, van der Hulst RRWJ. Preclinical experience using a new robotic system created for microsurgery. Plast Reconstr Surg. 2018;142(5):1367-1376
  • Van Mulken TJM, Schols RM, Qiu SS, Brouwers K, Hoekstra LT, Booi DI, Cau R, Schoenmakers F, Scharmga AMJ, van der Hulst RRWJ. Robotic (super) microsurgery: Feasibility of a new master-slave platform in an in vivo animal model and future directions. J Surg Oncol. 2018;118(5):826-831
  • Cau R, Schoenmakers FBF, Steinbuch M, van Mulken TJM, van der Hulst RRWJ. Design and preliminary test results of a novel microsurgical telemanipulator system. 5th IEEE RAS/EMBS International Conference on Biomedical Robotics and Biomechatronics, Sao Paulo, 2014, pp. 352-356
  • Cau R. Design and realization of a master-slave system for reconstructive microsurgery. Eindhoven: Eindhoven University of Technology; 2014

Languages

  • English
  • Dutch
  • German

 

Also see these experts

Philipp Reichl

Philipp Reichl

  • European and German Patent and Trademark Attorney, European Patent Litigator
  • Associate
Bart Jan Niestadt

Bart Jan Niestadt

  • European, Dutch and Belgian Patent Attorney, European Patent Litigator
  • Partner
More experts

News

Patenting AI inventions: how to protect artificial intelligence innovations

As AI and machine learning advance, protecting innovations based on these technologies is essential to securing IP and capitalizing on efforts. For an AI invention to be patentable, it must have a “technical character,” meaning it must use technical means to solve a technical problem. A software module that applies a machine learning model is […]Continue reading

What about your ‘T & C’?

The importance of terms and conditions is often underestimated – writing the two words in full is sometimes even too much. “Who reads them at all?”, ‘We don’t even know what’s in them ourselves’, ‘We rarely fall back on them’ and ‘Why would we want to put general terms and conditions forward if the cooperation […]Continue reading

Upcoming decision on legal criterion for ‘novelty’

One of the most important requirements for obtaining a patent on a product in Europe is that the product is novel. That means that before the day on which the patent application was filed, the product was not yet available to the public in any way.Continue reading

Events

Beta Business Days 2025

Martiniplaza, Leonard Springerlaan, Groningen, Netherlands

The Beta Business Days is a two-day event aimed at establishing contacts between companies and ambitious students from Groningen.

Continue reading